LAURENCE S. FARER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The editorial by Stead and Dutt (1) in the August 1980 issue brings to the attention of the internal medicine community a great advance in chemotherapy for tuberculosis that has reduced by half the required duration of treatment. The Arkansas method described is one good way, but not the only way, to give short-course chemotherapy, and this way is one good way, but not the only way, to treat tuberculosis. The real breakthrough was recognition of the remarkable efficacy of the isoniazid (INH)-rifampin (RIF) combination. The use of these two potent bactericidal drugs simply eliminates the need
FARER LS. Chemotherapy for Tuberculosis. Ann Intern Med. ;94:137. doi: 10.7326/0003-4819-94-1-137_3
Download citation file:
Published: Ann Intern Med. 1981;94(1):137.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use